Drug-induced linear immunoglobulin a bullous dermatosis mimicking Stevens-Johnson syndrome: A case report

Cutis

Volumn 79, Issue 3, 2007, Pages 203-207

  Cummings, Julie E ^a,c   Snyder, Renee R ^b   Kelly, Erica B ^a   Raimer, Sharon S ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b Private Practice   (United States)

^c BS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; IMMUNOGLOBULIN A; RIMANTADINE; ZANAMIVIR;

ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; SKIN; STEVENS JOHNSON SYNDROME;

ANTI-INFECTIVE AGENTS; AUTOIMMUNE DISEASES; AZITHROMYCIN; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; RIMANTADINE; SKIN; SKIN DISEASES, VESICULOBULLOUS; STEVENS-JOHNSON SYNDROME; ZANAMIVIR;

EID: 34147100675     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Chorzelski TP, Jablonska S, Beutner EH. Linear IgA bullous dermatosis. In: Beutner EH, Chorzelski TP, Bean SF, eds. Immunopcuhology of the Skin. New York, NY: Wiley; 1979:315-323.
2. Nousari HC, Kimyai-Asadi A, Caeiro JP, et al. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Mediane. 1999;78:1-8.
3. Dellavalle RP, Burch JM, Tayal S, et al. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J Am Acad Dermatol. 2003;48 (suppl 5):S56-S57.
4. Primka EJ III, Liranzo MO, Bergfeld WF, et al. Amiodarone-induced linear IgA disease. J Am Acad Dermatol. 1994;31:809-811.
5. Shimanovich I, Rose C, Sitaru C, et al. Localized linear IgA disease induced by ampicillin/sulbactam. J Am Acad Dermatol 2004;51:95-98.
6. Femiano F, Scully C, Gombos F. Linear IgA dermatosis induced by a new angiotensin-converting enzyme inhibitor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:169-173.
7. Pena-Penabad C, Rodriguez-Lozano J, del Pozo J, et al. Lineal IgA bullous dermatosis induced by angiotensin receptor antagonists. Am J Med. 2003;114:163-164.
8. Kuechle MK, Stegemeir E, Maynard B, et al. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol. 1994;30.-187-192.
9. Friedman IS, Rudikoff D, Phelps RG, et al. Captopril-triggered linear IgA bullous dermatosis. Int J Dermatol. 1998;37:608-612.
10. Cohen LM, Ugent RB. Linear IgA bullous dermatosis occurring after carbamazepine. J Am Acad Dermatol. 2002;46(suppl 2):S32-S33.
11. Gabrielsen T, Staerfelt F, Thune PO. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane. Acta Derm Venereal. 1981;61:439-441.
12. Cerottini J, Ricci C, Guggisberg D, et al. Drug induced linear IgA bullous dermatosis probably induced by furosemide. J Am Acad Dermatol. 1999;41:103-105.
13. del Pozo J, Martinez W, Yebra-Pimentel MT, et al. Linear immunoglobulin A bullous dermatosis induced by gemcitabihe. Ann Pharmacother. 2001;35-.891-893.
14. Tranvan A, Pezen DS, Medenica M, et al. Interleukin-2 associated linear IgA bullous dermatosis. J Am Acad Dermatol 1996;35(5 pt 2):865-867.
15. McWhirter JD, Hashimoto K, Fayne S, et al. Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol. 1987;123:1120-1122.
16. Bouldin MB, Clowers-Webb HE, Davis JL, et al. Naproxen-associaced linear IgA bullous dermatosis: case report and review. Mayo Clin Proc. 2000;75:967-970.
17. Wakelin SH, Alien J, Zhou S, et al. Drug-induced linear IgA disease with antibodies to collagen VII. BT J Dermatol. 1998;138:310-314.
18. Acostamadiedo JM, Perniciaro C, Rogers R. Phenytoininduced linear IgA bullous disease. J Am Acad Dermatol. 1998;38(2 pt 2):352-356.
19. Camilleri M, Pace JL. Linear IgA bullous dermatosis induced by piroxicam. J Eur Acad Dermatol Venereol. 1998;10:70-72.
20. Plunkett RW, Chiarello SE, Beutner EH. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. J Am Acad Dermatol. 2001;45:691-696.
21. Paul C,Wolkenstein P, Prost C, et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol. 1997;136:406-411.
22. Perrett CM, Evans AV, Russell-Jones R. Tea tree oil dermatitis associated with linear IgA disease. Clin Exp Dermatol. 2003;28:167-170.
23. Pellicano R, lannantuono M, Lomuto M. Pemphigus erythematosus induced by ceftazidime. Int J Dermatol. 1993;32:675-676.
24. Gange RW, Rhodes EL, Edwards CO, et al. Pemphigus induced by rifampicin, Br J Dermatol. 1976;95:445-448.
25. Downie JB, Dicostanzo DP, Cohen SR. Pemphigus vegetans-Neumann variant associated with intranasal heroin abuse. J Am Acad Dermatol. 1998;39(5 pt 2): 872-875.
26. Sehgal VN, Sriva&tava G. Corticosteroid-unresponsive pemphigus vulgaris following antiepileptic therapy. Int J Dermatol. 1988;27:258.
27. Lambert J, Schepens P, Janssens J, et al. Skin lesions as a sign of subacute pentachlorophenol intoxication. Acta Derm Venereal. 1986;66:170-172.
28. Patterson CR, Davies MG. Carbamazepine-induced pemphigus. Clin Exp Dermatol. 2003;28:98-99.
29. Cetkovska P, Pizinger K. Childhood pemphigus associated with montelukast administration. Clin Exp Dermatol. 2003;28:328-329.
30. Toth GG, Jonkman ME Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins. Br J Dermatol. 1999;141:583-585.
31. Butt A, Burge SM. Pemphigus vulgaris induced by captopril. Br J Dermatol, 1995;132:315-316.
32. Duhra P, Foulds IS. Penicillin-induced pemphigus vulgaris. Br J Dermatol. 1988;118:307.
33. Bayramgurler D, Ercin C, Apaydin R, et al. Indapamide-induced pemphigus foliaceus. J Dermatolog Treat. 2001;12:175-177.
34. Martin RL, McSweeney GW, Schneider J. Fatal pemphigus vulgaris in a patient taking piroxicam. N Engl J Med. 1983;309:795-796.
35. Weller R, White MI. Bullous pemphigoid and penicillamine. Clin Exp Dermatol. 1996;21:121-122.
36. Baz K, Ikizoglu G, Kaya TI, et al. Furosemide-induced bullous pemphigoid. J Eur Acad Dermatol Venereal. 2002;16:81-82.
37. Alcalay J, David M, Ingber A, et al. Bullous pemphigoid mimicking bullous erythema multiforme: an untoward side effect of penicillins. J Am Acad Dermatol. 1988;18:345-349.
38. Kashihara M, Danno K, Miyachi Y, et al. Bullous pemphigoid-like lesions induced by phenacetin: report of a case and an immunopathologic study. Arch Dermatol. 1984;120:1196-1199.
39. Quartey-Papafio CM, Hudson PM. Bullous pemphigoid initially localized to sites of burns (scalds) in a patient on sulphasalazine for ulcerative colitis. Clin Exp Dermatol. 1994;19:281.
40. Boulinguez S, Bernard P, Bedane C, et al. Bullous pemphigoid induced by bumetanide. Br J Dermatol. 1998; 138:548-549.
41. Modeste AB, Cordel N, Courville P, et al. Bullous pemphigoid induced by spironolactone [in French]. Ann Dermatol Venereal. 2002;129:56-58.
42. Millard TP, Smith HR, Black MM, et al. Bullous pemphigoid developing during systemic therapy with chloroquine. Clin Exp Dermatol. 1999;24:263-265.